MoFo represented Kamada Ltd. in its $59.4 million initial public offering on Nasdaq of 6.4 million shares at $9.25 per share. Headquartered in Israel, Kamada is a biopharmaceutical company that develops, produces and markets specialty therapeutics in more than 15 countries worldwide. Morgan Stanley & Co. LLC and Jefferies LLC acted as underwriter representatives and joint book-running managers. RBC Capital Markets, LLC and Oppenheimer & Co. Inc. acted as co-managers.
The MoFo team advising Kamada included San Francisco senior partner Bruce Mann, partner Andrew Thorpe and associates Kevin Yung and Anand Parikh.